Skip to main content
Scroll Top
Menu
WHO WE ARE
ABOUT US
TEAM
MANAGEMENT TEAM
INDUSTRIAL ADVISORS
SCIENTIFIC COUNCIL
PARTNERS
R&D
INTRODUCTION
TECH
NEUROSTIMULATION
PHOTOBIOMODULATION
ALZHEIMER
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
CONCUSSION
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
SOLUTIONS
CLINICAL RESEARCH
PRECLINICAL RESEARCH
CONCUSSION
NEWS
ALL
PRESS ARTICLES
VIDEOS
EVENTS
SCIENTIFIC PUBLICATIONS
ALL
SCIENTIFIC ARTICLES
ORAL COMMUNICATIONS
POSTED COMMUNICATIONS
CONTACT
FAQ
Executive summary
Français
Menu
WHO WE ARE
ABOUT US
TEAM
MANAGEMENT TEAM
INDUSTRIAL ADVISORS
SCIENTIFIC COUNCIL
PARTNERS
R&D
INTRODUCTION
TECH
NEUROSTIMULATION
PHOTOBIOMODULATION
ALZHEIMER
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
CONCUSSION
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
SOLUTIONS
CLINICAL RESEARCH
PRECLINICAL RESEARCH
CONCUSSION
NEWS
ALL
PRESS ARTICLES
VIDEOS
EVENTS
SCIENTIFIC PUBLICATIONS
ALL
SCIENTIFIC ARTICLES
ORAL COMMUNICATIONS
POSTED COMMUNICATIONS
CONTACT
FAQ
Executive summary
Français
Home
Tag
[Initiatives] Two new centers open in Paris for a clinical trial on Alzheimer’s disease
Alzheimer
15 March 2026
[Initiatives] Two new centers open in Paris for a clinical trial on Alzheimer’s disease
Alzheimer’s: REGEnLIFE opens two new centres in Paris for its clinical trial
Alzheimer
15 March 2026
Alzheimer’s: REGEnLIFE opens two new centres in Paris for its clinical trial
France TV – Health: innovations that will amaze you – December 3 2025
6 March 2026
France TV – Health: innovations that will amaze you – December 3 2025
France INTER highlights our Light4Life clinical trial for Alzheimer’s patients
6 March 2026
France INTER highlights our Light4Life clinical trial for Alzheimer’s patients
USPALZ 2025 : Congrés des Unités de Soins, d’évaluation et de Prise en charge ALZheimer – Issy-les-Moulineaux | 10-11 décember
Past Events
6 March 2026
USPALZ 2025 : Congrés des Unités de Soins, d’évaluation et de Prise en charge ALZheimer – Issy-les-Moulineaux | 10-11 décember
Prix Galien USA Awards 2025 – New York | October 30
Past Events
6 March 2026
Prix Galien USA Awards 2025 – New York | October 30
NEXii Longevity Congress 2025 – Porto | October 8-9
Past Events
6 March 2026
NEXii Longevity Congress 2025 – Porto | October 8-9
17th edition of the Francophone Meetings on Alzheimer’s Disease and Related Syndromes (RFMASA) – Lausanne | 29 September to 1st October 2025
Past Events
6 March 2026
17th edition of the Francophone Meetings on Alzheimer’s Disease and Related Syndromes (RFMASA) – Lausanne | 29 September to 1st October 2025
Alzheimer’s disease: the promise of new Non-Invasive Brain Stimulation methods
Alzheimer
Posted Communications
5 March 2026
Alzheimer’s disease: the promise of new Non-Invasive Brain Stimulation methods
Neurointestinal stimulation: a new therapeutic approach for Alzheimer’s disease? News from the pivotal clinical trial LIGHT4LIFE
Alzheimer
Oral Communications
5 March 2026
Neurointestinal stimulation: a new therapeutic approach for Alzheimer’s disease? News from the pivotal clinical trial LIGHT4LIFE
Photobiomodulation Therapy: A Novel Therapeutic Approach to Alzheimer’s Disease Made Possible by the Evidence of a Brain-Gut Interconnection
Alzheimer
Scientific Articles
29 May 2024
Photobiomodulation Therapy: A Novel Therapeutic Approach to Alzheimer’s Disease Made Possible by the Evidence of a Brain-Gut Interconnection
Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer’s Disease
Alzheimer
Scientific Articles
11 March 2024
Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer’s Disease
Prev
1
2
3
4
Next
Get a Quote
Hidden fields
![[Initiatives] Two new centers open in Paris for a clinical trial on Alzheimer’s disease](https://regenlife.com/wp-content/uploads/2026/09/transparent-thegem-product-justified-square-m.png)
